A phase i study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia

Lukas D. Wartman; Mark A. Fiala; Theresa Fletcher; Emily R. Hawkins; Amanda Cashen; John F. DIpersio; Meagan A. Jacoby; Keith E. Stockerl-Goldstein; Iskra Pusic; Geoffrey L. Uy; Peter Westervelt; Ravi Vij

doi:10.3109/10428194.2015.1076930

A phase i study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia

Lukas D. Wartman
, Mark A. Fiala
, Theresa Fletcher
, Emily R. Hawkins
, Amanda Cashen
, John F. DIpersio
, Meagan A. Jacoby
, Keith E. Stockerl-Goldstein
, Iskra Pusic
, Geoffrey L. Uy
, Peter Westervelt
, Ravi Vij

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	728-730
Number of pages	3
Journal	Leukemia and Lymphoma
Volume	57
Issue number	3
DOIs	https://doi.org/10.3109/10428194.2015.1076930
State	Published - Mar 3 2016

Access to Document

10.3109/10428194.2015.1076930

Cite this

Wartman, L. D., Fiala, M. A., Fletcher, T., Hawkins, E. R., Cashen, A., DIpersio, J. F., Jacoby, M. A., Stockerl-Goldstein, K. E., Pusic, I., Uy, G. L., Westervelt, P., & Vij, R. (2016). A phase i study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia. Leukemia and Lymphoma, 57(3), 728-730. https://doi.org/10.3109/10428194.2015.1076930

@article{0664dafcd103499dba060df818188923,

title = "A phase i study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia",

author = "Wartman, \{Lukas D.\} and Fiala, \{Mark A.\} and Theresa Fletcher and Hawkins, \{Emily R.\} and Amanda Cashen and DIpersio, \{John F.\} and Jacoby, \{Meagan A.\} and Stockerl-Goldstein, \{Keith E.\} and Iskra Pusic and Uy, \{Geoffrey L.\} and Peter Westervelt and Ravi Vij",

note = "Funding Information: Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.",

year = "2016",

month = mar,

day = "3",

doi = "10.3109/10428194.2015.1076930",

language = "English",

volume = "57",

pages = "728--730",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

number = "3",

}

TY - JOUR

T1 - A phase i study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia

AU - Wartman, Lukas D.

AU - Fiala, Mark A.

AU - Fletcher, Theresa

AU - Hawkins, Emily R.

AU - Cashen, Amanda

AU - DIpersio, John F.

AU - Jacoby, Meagan A.

AU - Stockerl-Goldstein, Keith E.

AU - Pusic, Iskra

AU - Uy, Geoffrey L.

AU - Westervelt, Peter

AU - Vij, Ravi

N1 - Funding Information: Disclosure forms provided by the authors are available with the full text of this article at www.informahealthcare.com/lal.

PY - 2016/3/3

Y1 - 2016/3/3

UR - https://www.scopus.com/pages/publications/84945205450

U2 - 10.3109/10428194.2015.1076930

DO - 10.3109/10428194.2015.1076930

M3 - Letter

C2 - 26674111

AN - SCOPUS:84945205450

SN - 1042-8194

VL - 57

SP - 728

EP - 730

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 3

ER -

A phase i study of carfilzomib for relapsed or refractory acute myeloid and acute lymphoblastic leukemia

Access to Document

Other files and links

Cite this